Market Report Titled “Precision Medicine Market Research Report – Forecast to 2025” is a Specialist Examination Report Explores the Market by Research Methodology, Segmentation, Key Players, and Major Region Globally.
Precision Medicine Market Overview:
The report on a global scale regarding the precision medicine market would witness a rise by 12.48% CAGR during the forecast period encompassing 2019-2025 to reach and surpass a valuation by USD 126.14 billion. Market Research Future (MRFR) revealed that this growth would be substantial due to the inclusion of high throughput sequencing, increasing expenditure from several private companies and governments, development in the structure of the healthcare sector, better participation from pharmaceutical companies, growing rate of chronic diseases, and others. High chance of recovery would also trigger better precision medicine market expansion in the coming few years.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/925
Precision Medicine Market Segmentation:
The global market report on precision medicine can be segmented into ecosystem players, sub-markets, and therapeutics. This is to facilitate a proper study that would determine the growth of the global market in the coming years.
By ecosystem players, the report on the global precision medicine market can be segmented into diagnostic companies, healthcare IT specialists/big data companies, pharmaceuticals and biotechnology companies, and clinical laboratories. The diagnostic tool companies segment has a substantial opportunity for growth from its previous valuation of USD 16.27 million in 2017.
By sub-markets, the global report on the precision medicine market can be segmented into companion diagnostics, targeted therapeutics, biomarker-based tests, molecular diagnostics, pharmacogenomics (PGX), and others.
By therapeutics, the global study containing the precision medicine market includes cardiovascular disease (CVD), cancer/oncology, infectious diseases, central nervous system, and others.
Precision Medicine Market Regional Market:
The market in America would lead the global scenario as it would be led by the US where the structure to support such researches are stronger than its peers. Along with it, the presence of Canada would boost the market outcome further. The regional market in the Northern part would see a constant flow of investment and a high inclusion rate of latest technologies. Better capacity to avail such methods would boost the market further. In the Southern region, this growth would be sluggish due to the presence of countries with poor infrastructure and investment capacity.
In Europe, growth would be backed by government initiatives to bolster the research facilities and investments from pharmaceutical companies. The latter is a common trait for both North America and Europe. In Asia Pacific, these companies would launch extensive expansion plans in growing economies where the healthcare sector is witnessing a surge in activities.
Precision Medicine Market Competitive Analysis:
The global precision medicine market report includes discussions regarding various types of strategic moves taken by top-players like Almac Group, Ltd., ABBOTT LABORATORIES, bioMérieux SA, ASURAGEN, INc., GlaxoSmithKline Plc (GSK), Cepheid Inc., CETICS Healthcare Technologies GmbH, GE Healthcare, Johnson & Johnson, Intomics A/S, Medtronic, Novartis, LABORATORY CORPORATION OF AMERICA HOLDINGS, Qiagen, Pfizer Inc, Randox Laboratories Ltd, BIOBASE GmbH (Subsidiary), Quest Diagnostics Inc., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Roche Holding AG-Br, Caris Life Sciences, HealthCore, Inc., Teva Pharmaceutical Industries Ltd., Intel Corporation, Molecular Health GmbH, AB-Biotics SA, InnVentis, IBM, and Precision for Medicine. These players are known for their strategic moves like mergers, increasing investment in various research and development facilities, collaborations, and others.
Precision Medicine Industry News:
In March 2020, researchers from Nemour’s Children’s Health System announced that they had identified a new type of variant in genetic structure that will help in manufacturing personalized drugs for patients with leukemia. Many researchers are looking at this as a possible counter-attack against the cancer. Researchers have suggested using next-generation sequencing that would increase precision in the detection of the process.
TABLE OF CONTENT
1 Report Scope$
1.1 Scope Of The Study 26
1.2 Precision Medicine: Report Coverage 27
1.3 Research Methodology 29
1.3.1 Research Methodology For The Global Market Study 30
1.3.2 Global Precision Medicine: Research Methodology 32
1.3.3 Key Data Point Sources 33
1.4 Report Description 34
2 Executive Summary$ 1,350.00
3 Market Overview$
3.1 Introduction 42
3.2 Market Timeline 42
3.3 Key Participants, Strategies & Developments 50
3.3.1 Government Agencies 50
3.3.2 Academic Institutions 50
3.3.3 Device & Service Providers 51
3.4 Key Market Strategies And Developments 51
3.4.1 Introduction 51
3.4.2 Partnerships, Agreements, And Collaborations 52
3.4.3 Mergers & Acquisitions 54
3.4.4 Product Development And Launch 56
3.4.5 Business Expansion/Contracts 57
3.4.6 Patents, Approvals, And Certifications 59
3.4.7 Others (Events & Recognitions) 60
4 Market Dynamics$ 950.00
4.1 Introduction 61
4.2 Market Drivers 62
4.2.1 Patients Involvement In Personal Healthcare 62
4.2.2 Technologies Driving The Market (Next-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)..64
4.2.3 Increase In Genetic Diseases 64
4.2.4 Potential For More Targeted Therapies 65
4.2.5 Integration Of Big Data Healthcare Companies With Pharma & Biotech Companies 65
4.3 Market Challenges 66
4.3.1 Potential Threat To Personal Data 66
4.3.2 High Diagnostic Cost As A Barrier 67
4.3.3 Potential Risk Of Hardware Or Software Failure 68
4.3.4 Stringent Regulations And Standards 68
4.3.5 Lack Of Awareness About The Possible Applications Of Precision Medicine 70
4.3.6 Reimbursement Policies And Regulatory Framework 71
4.3.7 Limited Knowledge About The Application Of Test And Techniques 71
4.3.8 Lack Of Research And Evidences Creating Hindrances In Its Application 72
4.4 Market Opportunities 73
4.4.1 Introduction Of Precision Medicine Solutions In Developing Economies 73
4.4.2 Downsizing The Cost Of Genome Sequencing To Three Digits 74
5 Industry Dynamics
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/precision-medicine-market-925
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar